ROCHLIN KATE (Chief Operating Officer) received a stock award from IN8BIO, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/23/2025ACC: 0001898521-25-000003
Officer· Chief Operating Officer
Since Dec 2021
+7.25K
Net shares
Net buyer
$10.0K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
7.25K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+7.25K
Price / share
$1.38
Trade value
$10K
% of position
394.3%
12/22/2025
1.84K→9.09K
Total
Net shares
+7.25K
Net value
$10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/22/2025 | A · Award | +7.25K | $1.38 | $10K | 394.3% | 1.84K | 9.09K |
| Total | +7.25K | $10K | ||||||
Derivative Transactions0
No derivative transactions reported